N@N

RL, LXK, FRX, PFE, FE, RDC Expected to Trade Higher After Bullish Patterns Develop

^{Published on 2011-02-09 14:11:25 - WOPRAI}
 

February 9, 2011 / M2 PRESSWIRE / BUYINS.NET / http://www.squeezetrigger.com is monitoring top technical trading patterns and these stocks are the most likely to trade Higher in the coming weeks. POLO RALPH LAUREN CORP (NYSE:RL), LEXMARK INTERNATIONAL INC-A (NYSE:LXK), FOREST LABORATORIES INC (NYSE:FRX), PFIZER INC (NYSE:PFE), FIRSTENERGY CORP (NYSE:FE), ROWAN COMPANIES INC (NYSE:RDC) are all expected to go Higher as Buy signals have been generated by top technical trading patterns. We monitor these patterns: Support Break, Support Reversal, Breakaway Gap, Measured Gap, Exhaustion Gap, Resistance Break, Resistance Reversal, Saucer Reversal, Volume Climax, Volume Trend, Fibonacci Reversal, Consolidation Breaks, Trend Line Break,Trend Line Reversal, Candles, Golden Crosses, Death Crosses and more. The chart below displays the stocks expected to go Higher along with pattern, strategy and strength ratings.

     Symbol     Company                             Strategy                Pattern Name            Strength  
     RL         POLO RALPH LAUREN CORP              ARM4R2STK_Support(Longs)     Resistance Break(1)     5         
     LXK        LEXMARK INTERNATIONAL INC-A         ARM4R2STK_Consolidations(Longs)     Trend Line Reversal(4)     3         
     FRX        FOREST LABORATORIES INC             ARM4R2STK_Trendlines(Longs)     Trend Line Break(3)     4         
     PFE        PFIZER INC                          ARM4R2STK_Consolidations(Longs) (+1)     Broadening Continuation     5         
     FE         FIRSTENERGY CORP                    ARM4R2STK_Support(Longs)     Resistance Break(1)     4         
     RDC        ROWAN COMPANIES INC                 ARM4R2STK_Gaps(Longs)     Trend Line Break(4)     5         

Chart Pattern Recognition is based on a 20-year patterns database. This database is used to determine pattern strength for patterns as they appear. There is no optimization and the pattern signals never change. For each pattern variation, we record accuracy and profitability statistics in a patterns database. From this information, we are able to define strength ratings from 1 to 5. The '1' rating shows ALL patterns while a '5' rating shows the best patterns according to profitability. Each pattern has its own strength rating factors. The result is an automatic ranking system that allows us to only show the BEST patterns. You can see that, at Strength 5, virtually all the patterns are profitable. The pattern strength rating system separates the most profitable patterns. The specific technology used to make these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/sw/ot.php

POLO RALPH LAUREN CORP (NYSE:RL) - Polo Ralph Lauren Corporation, together with its subsidiaries, engages in the design, marketing, and distribution of lifestyle products worldwide. It offers mens, womens, and childrens clothing; and accessories comprising footwear, eyewear, watches, jewelry, hats, and belts, as well as leather goods, including handbags and luggage. The company also provides products for homes, including bedding and bath products, furniture, fabric and wallpaper, paint, tabletop, and giftware; and fragrance products under Romance, Polo, Lauren, Safari, Ralph, and Black Label brands. In addition, it licenses its products, such as mens sportswear, mens tailored clothing, mens underwear and sleepwear, eyewear, and fragrances. The company sells its products to department stores, specialty stores, and golf and pro shops; full-price retail stores and factory stores; and online through RalphLauren.com and Rugby.com. As of March 28, 2009, it operated 163 full-price retail stores and 163 factory stores. Polo Ralph Lauren Corporation was founded in 1967 and is based in New York, New York.

LEXMARK INTERNATIONAL INC-A (NYSE:LXK) - Lexmark International, Inc. develops, manufactures, and supplies printing and imaging solutions for offices. It offers laser printers, inkjet printers, and multifunction devices, as well as cartridges and other supplies, services, and solutions. The company also sells dot matrix printers for printing single and multi-part forms by business users. In addition, it offers maintenance, consulting, and systems integration services, as well as provides managed print services, including asset lifecycle management, implementation and decommissioning services, consumables management, optimization services, and utilization management. Lexmark International serves large enterprises, small and medium businesses, and small offices/home offices. The company offers its products primarily through resellers, retailers, and distributors, as well as through solution providers, discount store chains, consumer electronics stores, office superstores, wholesale clubs, OEM arrangements, and online. It operates in North and South America, Europe, the Middle East, Africa, Asia, the Pacific Rim, and the Caribbean. The company was founded in 1990 and is headquartered in Lexington, Kentucky.

FOREST LABORATORIES INC (NYSE:FRX) - Forest Laboratories, Inc. develops, manufactures, and sells branded and generic forms of ethical drug products. Its principal products include Lexapro to treat depression; Namenda to treat Alzheimer's disease; Bystolic, beta-blocker to treat hypertension; and Savella for the treatment of fibromyalgia. The company also provides Sudocrem, a topical preparation to treat diaper rash; Colomycin, an antibiotic to treat cystic fibrosis; Infacol, which is used to treat infant colic; and Exorex, which is to treat eczema and psoriasis. In addition, its products include Dutogliptin, a small molecule dipeptidyl-peptidase-4 inhibitor, which is in Phase III studies to treat Type II diabetes mellitus; F2695 that completed Phase II study and is a selective norepinephrine and serotonin reuptake inhibitor for the treatment of depression and other central nervous system disorders; and ceftaroline acetate, a injectable cephalosporin antibiotic that exhibits bactericidal activity against the strains of gram-positive bacteria. Further, the companys products comprise NXL104, an intravenous beta-lactamase inhibitor; Linaclotide for the treatment of constipation-predominant irritable bowel syndrome and chronic constipation; Aclidinium, an inhaling therapy, which is in Phase III studies for chronic obstructive pulmonary disease; and Cariprazine, an atypical antipsychotic in Phase II(b) studies for the treatment of schizophrenia, bipolar mania, and other psychiatric conditions. Additionally, its products include Oglemilast, a phosphodiesterase-IV inhibitor in Phase II study to treat COPD and asthma; and Benicar, an angiotensin receptor blocker to treat hypertension. The company has collaboration and license agreements Phenomix Corporation, Pierre Fabre Medicament, Novexel, S.A., Laboratorios Almirall, S.A., Gedeon Richter Ltd., Glenmark Pharmaceuticals Ltd., and AstraZeneca plc. Forest Laboratories, Inc. was founded in 1956 and is based in New York, New York.

PFIZER INC (NYSE:PFE) - Pfizer Inc., a biopharmaceutical company, engages in the discovery, development, manufacture, and marketing of prescription medicines for humans and animals worldwide. The companys Biopharmaceutical segment offers products in the areas of primary care, specialty care, established products, emerging markets, and oncology customer-focused units. Its principal products include Lipitor for elevated cholesterol levels in the blood; Norvasc for hypertension; Caduet for cardiovascular events; Chantix/Champix for smoking cessation; Lyrica for neuropathic pain; Revatio for pulmonary arterial hypertension; Geodon/Zeldox, a psychotropic agent; and Aricept for Alzheimers disease. This segments products also comprise Celebrex for osteoarthritis and rheumatoid arthritis and acute pain; Zyvox for Gram-positive pathogens; Viagra for erectile dysfunction; Detrol/ Detrol LA for overactive bladder; Sutent for advanced renal cell carcinoma; Xalatan for open-angle glaucoma and ocular hypertension; Genotropin for growth disorders; Vfend, an antifungal agent; Effexor for depressive disorders; Prevnar/Prevnar7 for invasive pneumococcal disease; Enbrel for rheumatoid arthritis; Protonix, proton pump inhibitor for erosive esophagitis; and Spiriva for breathing problems. The companys Diversified segment offers animal health products, which include antibiotics, anti-inflammatories, antiemetics, parasiticides, and vaccines; consumer healthcare products comprising dietary supplements, pain management, respiratory, and topicals/gastro-intestinal products; Nutrition products; and Capsugel products that include gelatin, liquid, softgel, non-animal, and fish gelatin capsules. Pfizer Inc. serves doctors, nurse practitioners, physician assistants, pharmacists, hospitals, pharmacy benefit managers, managed care organizations, and government agencies. It has a strategic alliance with Acacia Living Inc. The company was founded in 1849 and is headquartered in New York, New York.

FIRSTENERGY CORP (NYSE:FE) - FirstEnergy Corp. operates as a diversified energy company. The company, through its subsidiaries and affiliates, involves in the generation, transmission, and distribution of electricity, as well as energy management and other energy-related services. As of December 31, 2009, it served approximately 4.5 million customers within 36,100 square miles through its 8 utility operating companies primarily in Ohio, Pennsylvania, and New Jersey. The company was founded in 1996 and is headquartered in Akron, Ohio.

ROWAN COMPANIES INC (NYSE:RDC) - Rowan Companies, Inc. provides a range of onshore and offshore contract drilling services in the United States and internationally. As of December 31, 2009, it provided contract drilling services through a fleet of 23 self-elevating mobile offshore drilling platforms and 29 deep-well land drilling rigs. The company also designs and manufactures drilling equipment in a range of sizes, including mud pumps, top drives, draw-works, rotary tables, and electrical components, such as variable-speed motors and drives for the offshore and onshore oil and gas drilling industry. In addition, it manufactures heavy equipment, including large-wheeled front-end loaders, diesel-electric powered log stackers, and steel plate products. The company was founded in 1923 and is headquartered in Houston, Texas.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net